Treating Contact Dermatitis

Expert Evaluation and Evidence-Based Management

A red, intensely itchy rash that appeared where your watch sits. Swollen, cracked hands that never seem to fully heal no matter how much lotion you use. A breakout across your neck after trying a new perfume. Contact dermatitis is one of the most common skin conditions evaluated by dermatologists, and one of the most frequently mismanaged. The rash isn’t random. It has a cause. And identifying that cause is the difference between symptom control and lasting relief.

Contact dermatitis is an inflammatory skin reaction triggered by direct contact with a substance that either damages the skin chemically or provokes an immune response in a sensitized individual. It affects people of all ages and all skin types. It accounts for an estimated 95 percent of all occupational skin disease. And it is the most common cause of occupational illness among healthcare workers, hairdressers, construction workers, and food service employees. Despite its prevalence, it is frequently undertreated or misdiagnosed because it resembles several other eczematous and inflammatory skin conditions that require entirely different management approaches.

At Connolly Dermatology, we provide expert evaluation and contact dermatitis treatment guided by evidence-based care. Our board-certified dermatologists accurately identify whether your reaction is allergic, irritant, or another form of contact dermatitis, perform comprehensive patch testing when indicated, identify the specific substances responsible, and design a management plan that addresses the root cause rather than only suppressing your symptoms.

If you have a rash that keeps recurring, hands that won’t heal, or a reaction you can’t explain, scheduling an evaluation with a dermatologist provides clarity. Have your skin assessed by the specialists at Connolly Dermatology and get the answers you need to move forward confidently.

Understanding Contact Dermatitis

How the Different Types Differ and Why That Distinction Matters

Contact dermatitis is not a single disease. It is an umbrella term for several distinct inflammatory reactions that share a common feature: they are triggered by contact with external substances. The most clinically important distinction is between allergic contact dermatitis and irritant contact dermatitis, because they involve different mechanisms, require different diagnostic approaches, and have different management priorities. Treating one as the other produces poor results and perpetuates unnecessary suffering.

Irritant Contact Dermatitis

Irritant contact dermatitis is the most common form, accounting for approximately 70 to 80 percent of all contact dermatitis cases. It does not involve an immune response. Instead, it results from direct physical or chemical damage to the skin barrier by a substance that is cytotoxic to keratinocytes. When the skin’s barrier is disrupted, pro-inflammatory cytokines including interleukin-1 alpha and tumor necrosis factor-alpha are released, generating erythema, scaling, and discomfort. Any person exposed to sufficient concentrations of an irritant for sufficient duration will develop irritant contact dermatitis. No prior sensitization is required. The most common causes are water and wet work, soaps, detergents, solvents, acids, alkalis, and friction. The hands are the most frequently affected site because they bear the highest burden of chemical contact in daily life and occupational settings.

Allergic Contact Dermatitis

Allergic contact dermatitis is a Type IV delayed-type hypersensitivity reaction mediated by sensitized T lymphocytes. It develops in two immunologically distinct phases. During the sensitization phase, a small reactive chemical called a hapten penetrates the skin, binds to skin proteins, and is taken up by Langerhans cells and dendritic cells that migrate to regional lymph nodes. There, they present the hapten-protein complex to naive T cells, generating a population of allergen-specific memory T cells. This sensitization process typically takes 10 to 14 days after first exposure and produces no symptoms. During the elicitation phase, subsequent contact with the same allergen triggers the memory T cells to mount a rapid inflammatory response, releasing cytokines that produce the characteristic itchy, erythematous, vesicular rash. This reaction develops within 12 to 96 hours of re-exposure and persists for days to weeks. Once sensitized, an individual remains sensitized indefinitely. Crucially, any amount of the specific allergen can trigger a reaction in a sensitized person, regardless of concentration.

Photocontact Dermatitis

Photocontact dermatitis requires both a chemical applied to or ingested by the skin and exposure to ultraviolet light to generate the reaction. Phototoxic contact dermatitis is a non-immune reaction that can occur in anyone when a photosensitizing chemical absorbs UV energy and directly damages skin cells. It presents as an exaggerated sunburn in the distribution of both the chemical contact and the UV exposure. Photoallergic contact dermatitis is an immune-mediated reaction similar to allergic contact dermatitis, but the sensitizing antigen is formed only when the chemical is activated by UV light. Common photosensitizing agents include certain sunscreen ingredients, NSAIDs applied topically, and fragrances such as those containing bergapten. The characteristic distribution on sun-exposed skin, sparing areas covered by clothing, is the key clinical clue.

Systemic Contact Dermatitis

Systemic contact dermatitis occurs when a person previously sensitized to a contact allergen through skin exposure is subsequently exposed to that allergen systemically, through ingestion, inhalation, or injection. Common examples include systemic reactions to nickel through dietary sources, reactions to mercury from dental amalgam, and reactions to certain medications in patients sensitized to related chemicals. The presentation can be a widespread flare of previously affected skin, a pattern of flexural dermatitis, or the distinctive “baboon syndrome” pattern of symmetric erythema in the gluteal, inner thigh, and axillary areas.

Contact Dermatitis vs. Other Inflammatory Skin Conditions

Contact dermatitis closely resembles several other common inflammatory skin conditions. Selecting the correct diagnosis before treatment determines whether the chosen intervention actually addresses the underlying mechanism. The comparison below highlights key distinguishing features.

These patterns represent typical presentations. Individual cases frequently overlap, and a single patient can have both allergic and irritant contact dermatitis simultaneously. A board-certified dermatologist with patch testing expertise provides the definitive diagnosis.

Is Contact Dermatitis Dangerous?

Contact dermatitis itself is not dangerous in the sense of becoming cancerous or causing systemic organ damage. It does not become malignant. However, dismissing it as a minor inconvenience fails to account for its genuine and substantial impact on patients’ lives.

Severe or chronic contact dermatitis, particularly on the hands, can be disabling. Healthcare workers who develop severe hand dermatitis to latex, surgical scrub solutions, or rubber glove chemicals may be unable to continue practicing in their profession. Hairdressers sensitized to p-phenylenediamine in hair dye face the same career-ending risk. Severe acute reactions, particularly to poison ivy, oak, or sumac, can produce blistering eruptions requiring urgent medical management. Secondary bacterial infection of severely inflamed, weeping, or excoriated skin occurs in a meaningful proportion of untreated or undertreated cases and requires antibiotic therapy. And the chronic psychological burden of itchy, painful, visibly inflamed skin on the hands and face has been documented to produce clinically significant rates of anxiety, depression, and reduced quality of life comparable to other chronic skin conditions.

Signs and Symptoms of Contact Dermatitis

Contact dermatitis can look quite different depending on the type of reaction, the causative substance, the location of exposure, and whether the presentation is acute or chronic. Recognizing the characteristic features helps identify the condition accurately and guides appropriate evaluation.

Acute Contact Dermatitis

Acute contact dermatitis typically develops within hours to days of exposure and presents with a striking combination of erythema, edema, and vesiculation. The affected skin becomes red, swollen, and intensely itchy. Small to large vesicles form and may weep serous fluid, producing a wet, crusted appearance as the fluid dries. The border between inflamed and normal skin is sharp and geometric, often following the exact outline of the contacting substance. A watch that causes a rectangular rash on the wrist. Earrings that produce perfectly circular reactions on the earlobes. A rubber waistband that generates a linear band of inflammation across the abdomen. This geometric distribution is one of the most clinically useful diagnostic features of allergic contact dermatitis and distinguishes it clearly from conditions with more diffuse, non-patterned distributions.

Chronic Contact Dermatitis

When exposure to an allergen or irritant continues over weeks to months, the acute vesicular presentation transitions to the chronic phase. The skin becomes lichenified, meaning it thickens and develops an exaggerated skin line pattern from repeated scratching and rubbing. Fine scaling replaces weeping. Fissures and cracks develop, particularly on the hands, causing pain and bleeding with movement. The intense itch of the acute phase may become a persistent low-grade burning and tenderness. Chronic hand dermatitis is the most common form of chronic contact dermatitis and is frequently caused by combined allergic and irritant factors acting simultaneously on the same compromised skin barrier.

Location Patterns and What They Suggest

Hands: The most commonly affected site. Hand dermatitis can be irritant, allergic, or both. The distribution offers diagnostic clues. Dorsal hand and finger involvement with relative sparing of the palms suggests allergic contact dermatitis from topical products. Diffuse involvement of the entire hand and wrist including the palms is more consistent with irritant contact dermatitis from wet work. A specific finger ring pattern points to metal allergy, most commonly nickel.

Face: Facial contact dermatitis most commonly results from cosmetics, skincare products, hair care products, or airborne allergens. The eyelids are particularly sensitive and are frequently the primary or only site of allergic contact dermatitis to fragrances, preservatives, and nail polish allergens transferred by hand contact. Perioral reactions occur with toothpaste ingredients, lip balm constituents, and musical instrument contact.

Neck: Fragrance allergy is among the most common causes of neck contact dermatitis, from both perfumes applied directly and fragranced skincare products. Jewelry reactions, particularly to nickel in necklaces, present as patterned erythema at points of contact.

Scalp and Hairline: Hair dye reactions are among the most severe allergic contact dermatitis presentations. Para-phenylenediamine (PPD), the primary sensitizing agent in permanent hair dyes, produces intensely inflamed, edematous reactions at the hairline, ears, nape, and forehead. Severe PPD reactions can produce dramatic facial swelling.

Lower Legs and Feet: Lower leg contact dermatitis is common in patients with venous insufficiency who use topical medications and wound care products. Neomycin, bacitracin, and lanolin in common first-aid and wound care products are frequent sensitizers in this group. Shoe contact dermatitis from rubber chemicals, adhesives, and chromate in leather presents on the dorsal foot and occasionally the sole.

Trunk and Extremities: Clothing dye and textile finish allergens produce patterned reactions on the trunk, inner thighs, and axillae where fabric contact is closest. Rubber in waistbands, bra straps, and elastic produces characteristic geometric reactions.

Symptoms To Watch For

Most contact dermatitis produces a combination of:

•         Intense itching, which is the predominant symptom of allergic contact dermatitis
•         Burning or stinging, which is more prominent in irritant contact dermatitis
•         Erythema and swelling in the affected area
•         Vesicles or blisters in acute allergic reactions
•         Weeping and crusting as vesicles rupture
•         Dry, scaly, fissured, and cracked skin in chronic presentations
•         Pain and bleeding from hand fissures with movement

See a dermatologist promptly if you experience:

•         A rash that is spreading rapidly or producing significant swelling, particularly facial or eyelid swelling
•         Large blisters, widespread weeping, or signs of secondary infection (warmth, pus, increasing pain, fever)
•         A reaction you suspect is from poison ivy, poison oak, or poison sumac that involves the face or a large body area
•         Severe hand dermatitis that is interfering with work or daily activities
•         A rash that recurs in the same location after apparent healing
•         Persistent dermatitis that has not responded to over-the-counter hydrocortisone or emollient treatment
•         Any rash whose cause you cannot identify

Risk Factors for Developing Contact Dermatitis

Anyone can develop irritant contact dermatitis from sufficient exposure to a damaging substance. Allergic contact dermatitis is acquired through sensitization that can occur at any point in life, often after years of uneventful use of a product that has gradually breached the skin barrier threshold. Understanding who is at elevated risk and what substances most commonly cause reactions helps guide both prevention and early evaluation.

Occupation

Occupational contact dermatitis represents the most clinically significant risk domain. It accounts for an estimated 95 percent of all occupational skin disease, making it the most prevalent work-related illness across multiple industries. Healthcare workers face concentrated exposure to latex, rubber accelerators in gloves, quaternary ammonium disinfectants, chlorhexidine, glutaraldehyde, and the full spectrum of topical medications and wound care products. Hairdressers and cosmetologists are exposed to PPD in hair dyes, persulfate bleaching agents, and glyceryl thioglycolate in permanent wave solutions. Construction workers encounter chromate in cement, epoxy resins in adhesives, and rubber accelerators in protective equipment. Metalworkers are exposed to nickel, cobalt, and chromate in cutting fluids, metals, and industrial coatings. Food service workers face daily wet work combined with exposure to food allergens, spices, and preservatives. The combination of repeated wet work that compromises the barrier and concurrent allergen exposure creates the highest-risk environment for both irritant and allergic contact dermatitis.

Atopic Dermatitis

Individuals with atopic dermatitis have a fundamentally compromised skin barrier due to filaggrin gene mutations and reduced ceramide production. This compromised barrier allows enhanced penetration of potential allergens and irritants, increasing both the rate of sensitization and the severity of irritant reactions. Research demonstrates that people with atopic dermatitis have a significantly higher prevalence of contact allergies, particularly to fragrances, nickel, and preservatives, and are more susceptible to occupational hand dermatitis. For patients with both atopic dermatitis and contact allergy, identifying and eliminating the contact allergen component is essential because treating only the atopic component produces incomplete improvement.

Common Allergens: What Causes Allergic Contact Dermatitis

The North American Contact Dermatitis Group and the American Contact Dermatitis Society have systematically identified the most common contact allergens encountered in clinical practice through large-scale patch testing studies. The leading sensitizers include:

•         Nickel sulfate: The most common contact allergen worldwide. Found in jewelry, belt buckles, watch clasps, eyeglass frames, phone cases, and numerous everyday metal objects. Ear piercing is a major route of sensitization, particularly in young women.
•         Fragrances (Fragrance Mix I and II, Balsam of Peru): Present in perfumes, colognes, cosmetics, skincare products, shampoos, household cleaners, air fresheners, and numerous other personal care and household products. Among the most prevalent sensitizers in patch test series worldwide.
•         Preservatives (methylisothiazolinone, methylchloroisothiazolinone, formaldehyde, quaternium-15, DMDM hydantoin): Found in cosmetics, shampoos, conditioners, wet wipes, baby products, household cleaners, and industrial products. Methylisothiazolinone has emerged as a leading cause of epidemic allergic contact dermatitis as its use in leave-on products expanded.
•         Para-phenylenediamine (PPD): The primary allergen in permanent and semi-permanent hair dye. Cross-reacts with azo dyes in textiles, rubber chemicals, local anesthetics, and certain sunscreens. PPD sensitization can produce career-ending reactions in hairdressers and patients who color their hair regularly.
•         Topical antibiotics (neomycin, bacitracin): Among the most common sensitizers in patients with chronic wounds and venous ulcers who use over-the-counter antibiotic ointments for extended periods. Particularly important to identify in patients using these products on compromised leg skin.
•         Rubber accelerators (thiurams, carbamates, mercaptobenzothiazole): Used in the vulcanization of rubber products including gloves, shoes, elastic, condoms, and medical devices. Occupational sensitization in healthcare workers and the general population is common and clinically underrecognized.
•         Urushiol (poison ivy, poison oak, poison sumac): The single most common cause of acute allergic contact dermatitis in North America. Extraordinarily potent sensitizer; as little as one nanogram can elicit a reaction in a sensitized individual. Cross-reacts with mango skin, cashew shell oil, and lacquer tree resin.
•         Epoxy resins: Major occupational allergen in construction, aerospace, electronics, and adhesive manufacturing industries. Produces significant hand and forearm dermatitis in exposed workers.
•         Chromate (potassium dichromate): Found in cement, leather, metal alloys, and some paints. A leading cause of occupational contact dermatitis in construction and tanning industries. Leather shoe sensitization presents as dorsal foot dermatitis.

Common Irritants: What Causes Irritant Contact Dermatitis

The most common irritants encountered in clinical practice include wet work and water immersion, soaps and surfactants, detergents and cleaning products, organic solvents, acids and alkalis, physical friction and abrasion, and low-humidity environments. Repeated wet-dry cycles, in which the skin is repeatedly wetted and then dried, are among the most damaging patterns because each drying phase strips the barrier’s protective lipids, progressively reducing the skin’s capacity to resist subsequent damage.

Age

Older adults have naturally reduced barrier function, reduced sebaceous gland output, and impaired barrier repair capacity, making them more susceptible to irritant contact dermatitis and to sensitization from new allergens introduced through medications and wound care products. Children and adolescents are at elevated risk of nickel sensitization through ear piercing and jewelry contact during key developmental periods.

Can You Prevent Contact Dermatitis?

Allergic contact dermatitis can be prevented most effectively by avoiding sensitization in the first place, which is most achievable in occupational settings through product substitution, proper protective equipment, and barrier protection programs. Once sensitization has occurred, prevention means complete and permanent avoidance of the specific allergen. Identifying exactly which allergen to avoid requires professional patch testing. Guessing leads to incomplete avoidance and ongoing reactions.

Identify Your Allergens Through Patch Testing

The single most impactful prevention strategy for allergic contact dermatitis is knowing exactly what you are allergic to. Patch testing performed by a dermatologist identifies the specific substances triggering your reactions, enabling precise avoidance rather than broad elimination of entire product categories. Armed with a specific allergen list, you and your dermatologist can identify safe product alternatives and review every product in your current routine systematically.

Optimize Barrier Protection in High-Risk Settings

If your occupation involves significant wet work, chemical exposure, or repeated contact with known sensitizers, barrier protection is the primary preventive tool available. Select appropriate gloves for the specific chemical exposure, noting that no single glove material protects against all chemicals and that latex gloves themselves are a major sensitizer. Cotton liners under rubber gloves reduce sweat-related irritation. Barrier creams before work and emollient application after work and at the end of each day support barrier integrity against repeated daily damage.

Choose Fragrance-Free and Preservative-Minimized Products

Fragrances and preservatives are the most common sensitizers in cosmetics and personal care products. Choosing fragrance-free products, not simply “unscented” products which may still contain masking fragrances, substantially reduces sensitization risk. Similarly, products formulated without methylisothiazolinone and formaldehyde-releasing preservatives minimize exposure to the most prevalent emerging sensitizers in the current product landscape.

Seek Regular Dermatologic Monitoring in Occupational Settings

Workers in high-risk occupations benefit from dermatologic evaluation at the first sign of occupational skin disease. Early intervention, before sensitization is established or before barrier damage becomes severe, produces significantly better long-term outcomes than waiting until symptoms are chronic and treatment-resistant.

Diagnosis and Evaluation of Contact Dermatitis

Accurate diagnosis of contact dermatitis requires more than recognizing the rash. It requires identifying whether the reaction is allergic or irritant, locating the causative substance within the patient’s entire exposure history, and distinguishing contact dermatitis from the several conditions it closely mimics. The clinical examination provides the initial framework. Patch testing provides the definitive answer for allergic contact dermatitis. Both components together produce the specific, actionable diagnosis that makes successful management possible.

Clinical History

A detailed history is the most critical initial step in contact dermatitis evaluation. Your dermatologist will systematically review the timeline of your rash, noting when it first appeared, how it has changed, and whether it improves or worsens with specific activities, environments, or product use. Occupational history receives careful attention, including every chemical, product, and material you handle regularly at work. Your complete personal care and household product routine is reviewed: every shampoo, conditioner, facial cleanser, moisturizer, makeup product, sunscreen, perfume, and household cleaning agent. Recreational exposures, including gardening, hobbies, and outdoor activities where plant or chemical exposures occur, are explored. Prior dermatitis history and any previously identified allergies or reactions are documented. This detailed history frequently points toward the causative substance before any diagnostic testing begins.

Clinical Examination

Physical examination of the skin provides critical diagnostic information beyond the history. The distribution and morphology of the rash are the primary examination findings. Geometric, angular, or sharply demarcated patterns strongly suggest allergic contact dermatitis. The location of involvement, whether hands, face, neck, eyelids, or a specific body region, correlates with the category of likely causative agents and guides the selection of patch test panels. The dermatologist assesses whether the rash is in its acute vesicular phase, subacute crusted phase, or chronic lichenified phase, and whether secondary changes from scratching, secondary bacterial infection, or post-inflammatory dyspigmentation are present.

Patch Testing: The Gold Standard for Allergic Contact Dermatitis

Patch testing is the definitive diagnostic tool for identifying the specific allergen or allergens responsible for allergic contact dermatitis. It is performed in the dermatology office over a series of visits spanning 4 to 7 days and involves no needles, no blood draws, and no laboratory processing. Small chambers containing standardized concentrations of common allergens are applied to the upper back on Day 1. The chambers are left in place for 48 hours and removed at the Day 2 or Day 3 reading, at which point the skin is first examined. A final reading is performed at Day 4 to Day 7 to capture delayed reactions, which are characteristic of true allergic sensitization. Results are graded from negative to weak positive, strong positive, and extreme positive based on the presence and severity of erythema, papules, vesicles, and spreading reactions. A positive patch test reaction confirms sensitization to that substance and identifies it as a potential cause of the patient’s current dermatitis.

The standard panel used in most dermatology offices, the TRUE Test, contains 36 standardized allergens covering the most prevalent contact sensitizers in the general population. When occupational or specialized exposure histories suggest additional allergens, extended panels from the North American Contact Dermatitis Group series or the American Contact Dermatitis Society Core series, encompassing over 70 to 100 allergens, are used. Your dermatologist selects the panels most appropriate to your specific history. The results are interpreted in the context of your full exposure history by a physician experienced in patch testing, because a positive reaction only confirms sensitization, not necessarily current clinical relevance, and distinguishing relevant from incidental positives requires clinical judgment.

Potassium Hydroxide (KOH) Preparation

A skin scraping examined under a microscope after potassium hydroxide preparation can confirm or exclude tinea (fungal infection) when it cannot be distinguished from contact dermatitis clinically. Tinea pedis and tinea manuum on the hands and feet occasionally mimic contact dermatitis, and tinea corporis can produce a ring-shaped inflammatory lesion confused with contact reactions. This simple, in-office test takes minutes and definitively resolves the question when tinea is a diagnostic possibility.

Skin Biopsy

Skin biopsy is not routinely required for contact dermatitis but is indicated when the diagnosis remains uncertain after clinical examination and patch testing, or when a more serious condition such as cutaneous T-cell lymphoma or bullous pemphigoid cannot be excluded. The histopathologic findings in contact dermatitis, showing spongiosis and a mixed inflammatory infiltrate, are consistent with but not entirely specific to the condition and require correlation with clinical and patch test findings for accurate interpretation.

Repeated Open Application Test (ROAT)

When patch test results are equivocal or when a specific product is suspected but does not correspond to standard allergens, the repeated open application test provides additional information. The suspected product is applied to a small area of skin, typically the antecubital fossa, twice daily for up to four weeks without occlusion. A developing reaction confirms that the product is causing the patient’s dermatitis, though not necessarily which component within it. This test is simple, performed by the patient at home, and particularly useful for cosmetics and personal care products.

When Should You Get Contact Dermatitis Evaluated?

You should see a dermatologist if you notice:

•         A rash that recurs in the same location after apparent clearing, particularly on the hands, face, or neck
•         Hand dermatitis that has not fully resolved despite emollient use and reduced chemical exposure
•         A rash whose specific cause you cannot confidently identify
•         A reaction you suspect is related to your occupation or to a specific product in your routine
•         Eyelid swelling or redness that recurs after clearing
•         A widespread blistering reaction to poison ivy, oak, or sumac involving the face or a large body area
•         Secondary infection signs: warmth, pus, increasing pain, or fever associated with a contact dermatitis site
•         Any dermatitis in a patient with an occupation that places you in a high-risk category for occupational skin disease
•         Significant quality-of-life impact from chronic, recurrent, or painful skin involvement

Even when a contact dermatitis diagnosis is straightforward, professional patch testing identifies your specific allergen with certainty, enabling precise avoidance that produces dramatically better outcomes than the broad product elimination strategies most patients attempt on their own.

Contact Dermatitis Treatment Options

The most fundamental treatment for allergic contact dermatitis is avoidance of the specific causative allergen. No topical medication, systemic therapy, or procedure produces lasting relief if contact with the sensitizing substance continues. For irritant contact dermatitis, barrier repair and reduction of irritant exposure are the equivalent foundational interventions. All other treatments address the inflammation generated by ongoing or recent exposure and are appropriately understood as adjunctive to the primary goal of eliminating the cause.

Allergen Identification and Avoidance

Complete and permanent avoidance of the confirmed allergen is the only treatment for allergic contact dermatitis that addresses the root cause rather than symptoms. Following patch testing, your dermatologist provides a comprehensive list of your confirmed allergens and their synonyms, a list of safe product alternatives verified to be free of those allergens, guidance on which product categories to avoid, and counseling on cross-reactive substances that may trigger reactions even if they are chemically distinct from your primary allergen. The American Contact Dermatitis Society’s Contact Allergen Management Program (CAMP), an allergen avoidance database accessible to dermatologists, helps identify patient-safe products across hundreds of product categories. Patients who achieve complete allergen avoidance following accurate patch testing frequently experience complete and lasting remission without requiring ongoing treatment.

Wet Dressings and Soothing Compresses

For acute, weeping, and vesicular contact dermatitis, cool wet compresses applied for 15 to 30 minutes several times daily are the most immediately soothing and practically useful first-line intervention. They reduce erythema, relieve itch, draw out weeping fluid, and prepare the skin for subsequent topical treatment application. Plain water or aluminum acetate (Burow’s solution) compresses are both effective. This intervention is simple, available immediately, and significantly more comfortable than leaving acutely inflamed and weeping skin untreated.

Topical Corticosteroids

Topical corticosteroids are the primary anti-inflammatory treatment for contact dermatitis and the most consistently effective topical therapy available. Their potency must be matched carefully to both the severity of the reaction and the body site being treated to maximize efficacy while avoiding side effects. Low-potency agents such as hydrocortisone 1% or 2.5% are appropriate for the face, eyelids, and intertriginous areas where the skin is thin and absorbs topical agents more readily. Moderate-potency agents are used for the trunk and extremities. High-potency agents are reserved for thick, chronic, lichenified plaques on the palms and soles, which are the most resistant areas. Applied twice daily until the reaction clears, topical corticosteroids reduce erythema, itch, vesiculation, and scaling effectively. They are not a long-term solution when allergen exposure continues and should not be used indefinitely without medical supervision, as prolonged use produces skin atrophy, telangiectasia, and impaired barrier repair at treated sites.

Topical Calcineurin Inhibitors

Tacrolimus 0.1% ointment and pimecrolimus 1% cream are non-steroidal anti-inflammatory topical agents that suppress T-cell activation and the cytokine release driving the inflammatory response in allergic contact dermatitis. They are particularly valuable for facial and eyelid contact dermatitis where the risks of topical corticosteroid use are most significant, and for patients requiring long-term maintenance anti-inflammatory therapy in anatomically sensitive areas. Unlike topical corticosteroids, they do not produce skin atrophy and can be used safely for extended periods. They are somewhat less potent than moderate-strength corticosteroids for acute reactions but are the preferred agents for chronic facial involvement and for corticosteroid-sparing protocols.

Systemic Corticosteroids

For severe, widespread, or rapidly spreading allergic contact dermatitis, particularly poison ivy or oak reactions involving the face or a large body surface area, systemic corticosteroids provide rapid, effective anti-inflammatory control that topical agents cannot achieve. Oral prednisone at 0.5 to 1 mg per kilogram per day is the most commonly used regimen, tapered gradually over 14 to 21 days. This extended taper is critically important. Short 5-day courses, though common in urgent care and emergency settings, consistently produce rebound flares when discontinued because the underlying allergen exposure may still be present and the T-cell response has not fully resolved. An inadequately short steroid course followed by a rebound flare represents one of the most common and most preventable treatment failures in contact dermatitis management.

Emollients and Barrier Repair Therapy

Barrier repair is central to both the treatment of irritant contact dermatitis and the prevention of recurrent allergic contact dermatitis. Ceramide-containing emollients, barrier creams, and lipid-rich moisturizers replenish the structural components of the skin barrier that are depleted by irritant damage and inflammatory disease. Consistent emollient application after washing, before bed, and throughout the day for patients with hand dermatitis rebuilds barrier integrity, reduces transepidermal water loss, decreases skin sensitivity to subsequent irritant and allergen challenge, and significantly accelerates clinical recovery. Emollient selection must avoid fragrances, preservatives, and other common sensitizers, choosing products verified to be free of the patient’s specific allergens.

Oral Antihistamines

Oral antihistamines have a limited but practically useful role in contact dermatitis management. Because the itch of allergic contact dermatitis is driven by T-cell cytokines rather than histamine, non-sedating antihistamines have minimal effect on the itch itself. However, sedating first-generation antihistamines such as diphenhydramine or hydroxyzine, taken at bedtime, reduce the sleep disruption caused by intense nocturnal itching and prevent the scratching during sleep that perpetuates and worsens the inflammatory cycle. They are a useful adjunct to primary anti-inflammatory therapy rather than a standalone treatment.

Phototherapy

Narrowband ultraviolet B phototherapy is an effective treatment for chronic hand dermatitis, both allergic and irritant in origin, that has not responded adequately to topical therapy. Delivered in a series of in-office sessions typically three times per week, narrowband UVB suppresses the T-cell-mediated inflammatory response in the skin through immunomodulatory mechanisms, producing significant improvement in chronic dermatitis severity and itch. It is a well-established, evidence-supported intervention for refractory hand and dyshidrotic eczema and is an important treatment option for patients who have achieved optimal allergen avoidance but continue to have residual chronic inflammation.

Systemic Immunosuppressants for Chronic Refractory Disease

For patients with severe chronic contact dermatitis that has not responded to allergen avoidance, optimized topical therapy, and phototherapy, systemic immunosuppression provides meaningful disease control. Cyclosporine, methotrexate, azathioprine, and mycophenolate mofetil have all been used with documented benefit in chronic severe hand and body dermatitis. These agents are typically reserved for patients with significantly impaired quality of life or occupational function and require regular monitoring for toxicity. Decisions about systemic immunosuppressive therapy involve a careful assessment of disease severity, prior treatment history, comorbidities, and patient preference.

Emerging Therapies

Dupilumab, the IL-4/IL-13 receptor antagonist approved for atopic dermatitis, has demonstrated clinical benefit in a subset of chronic contact dermatitis patients, particularly those with concurrent atopic dermatitis or a Th2-skewed inflammatory profile. Its role in pure allergic contact dermatitis without an atopic background continues to be defined by ongoing clinical research. Tralokinumab and other emerging biologics targeting the Th2 cytokine axis are under investigation. For patients with treatment-resistant disease who have optimized allergen avoidance, these agents represent the most significant emerging advance in contact dermatitis management.

Managing Occupational Contact Dermatitis

Occupational contact dermatitis requires an approach that extends beyond standard dermatologic management to include workplace assessment and accommodation. Following identification of the occupational allergen or irritant, your dermatologist provides documentation supporting workplace accommodation requests including product substitutions, modified work practices, and protective equipment changes. In cases where continued exposure to the causative agent is unavoidable, proactive barrier protection protocols, regular emollient use, and optimized medical management minimize ongoing impact. Workers with severe, career-threatening occupational sensitization benefit from coordination between their dermatologist, occupational health services, and employer.

Why Choose Connolly Dermatology for Contact Dermatitis Treatment

Care Guided by Experience and Clinical Judgment

Contact dermatitis is extremely common, but its accurate diagnosis requires a level of clinical and diagnostic sophistication that most general medical settings cannot provide. Identifying the exact allergen, selecting the right patch test panels, interpreting the results in the context of the patient’s complete exposure history, and translating a positive result into a practical, product-specific avoidance strategy requires training, experience, and access to comprehensive allergen databases. Connolly Dermatology provides the full spectrum of contact dermatitis care from initial evaluation through patch testing, definitive allergen identification, and long-term management.

Board-Certified Dermatologists

Our dermatologists are trained in the complete evaluation and management of contact dermatitis across all its forms, from acute poison ivy reactions to complex chronic occupational hand dermatitis involving multiple simultaneous allergens and irritants. Every treatment recommendation reflects current clinical guidelines and the best available evidence.

Comprehensive Patch Testing

We perform comprehensive patch testing using both the standardized TRUE Test and, when indicated, extended panels aligned with North American Contact Dermatitis Group and American Contact Dermatitis Society series. Patch testing results are interpreted in the full context of your exposure history by a physician with expertise in contact allergen identification, not simply read as positive or negative. You receive a complete, interpreted allergen report along with practical guidance on what to avoid and which safe product alternatives are available.

Precise Allergen Avoidance Counseling

A positive patch test without detailed avoidance counseling produces incomplete results. At Connolly Dermatology, confirmed allergens are cross-referenced against current product databases so you receive a specific, actionable list of products that are safe for your skin and products to avoid, rather than broad and impractical guidance to eliminate entire product categories.

Multiple Evidence-Based Treatment Approaches

We offer wet dressing protocols, topical corticosteroids with site-appropriate potency selection, topical calcineurin inhibitors for steroid-sparing facial and chronic management, systemic corticosteroids for severe acute reactions with appropriate taper, emollient and barrier repair programs, phototherapy for chronic resistant hand dermatitis, and systemic immunosuppression for severe refractory disease. Your dermatologist designs the treatment strategy most appropriate to your specific presentation, severity, and treatment history.

Honest Communication About Outcomes

For allergic contact dermatitis, we tell every patient clearly: complete and permanent avoidance of your confirmed allergen is the most important component of your treatment, and no medication fully substitutes for eliminating the cause. We help you understand what successful management looks like for your specific situation and set expectations that reflect the realistic trajectory of your condition with appropriate intervention.

Patient Education and Support

Understanding what triggered your reaction, why certain substances cross-react, how to read ingredient lists, and how to modify your daily routine and work practices without eliminating safe products you rely on empowers you to manage contact dermatitis far more effectively. We make that education a core part of every contact dermatitis consultation.

Comfortable, Compassionate Care

Chronic hand dermatitis that interferes with work, facial reactions that affect appearance and confidence, and the persistent uncertainty of not knowing what is causing your rash all create genuine stress. Our team approaches every consultation with the sensitivity those experiences deserve, and we work to provide clear answers and real solutions as quickly as possible.

What To Expect During Treatment

Guiding You Through Evaluation and the Next Steps

Contact dermatitis evaluation at a dermatologist is often the first time a patient gets a definitive explanation for a rash they have been managing unsuccessfully on their own for months or years. At Connolly Dermatology, we guide you through every stage of your evaluation so you understand what is happening with your skin, what the diagnostic process involves, and what to expect as we work toward a clear answer and an effective treatment plan.

Before Your Appointment

Preparing thoroughly before your initial visit dramatically improves the quality and efficiency of your evaluation. In the two weeks before your appointment, do not apply topical corticosteroids to the areas planned for patch testing, as this suppresses reactions and produces false-negative results. Do not take oral corticosteroids, antihistamines, or other immunosuppressants if possible and as directed by your physicians. Prepare a comprehensive list of every topical product you use: shampoos, conditioners, cleansers, moisturizers, makeup, sunscreen, perfume, and any topical medications. Document your complete occupational exposure history including every chemical, material, and product you handle regularly at work. Note when your rash first appeared, how it has changed, whether it improves away from work or on vacation, and whether you have tried any treatments and how your skin responded. Bring a list of all current medications and any relevant medical history. This preparation is the foundation of a productive initial evaluation.

During the Initial Evaluation

Your dermatologist reviews your history in detail and then performs a focused physical examination of the affected areas and relevant nearby skin. They assess the distribution, morphology, and phase of the reaction and look for the geometric patterns and location clues that help identify the causative category of substance before testing begins. Dermoscopy or KOH preparation may be performed if alternative or concurrent diagnoses need to be excluded.

Your dermatologist explains what they are observing, shares their initial diagnostic impression, and discusses whether patch testing is indicated. For patients with clear irritant contact dermatitis from a known agent, focused management may begin immediately. For patients with a suspected or confirmed allergic component, patch testing is scheduled and explained in detail so you understand exactly what the process involves, how to prepare, what to expect during the testing days, and how to interpret the results.

During Patch Testing

Patch testing takes place across multiple visits over 4 to 7 days. On Day 1, the patch chambers are applied to your upper back and secured with hypoallergenic tape. You will be advised to keep the back dry, avoid vigorous exercise that causes significant sweating, and avoid direct UV sun exposure to the test sites during the testing period. On Day 2 or 3, you return to have the chambers removed and the first reading performed. On Day 4 to 7, you return for the final reading. You may experience itching at positive test sites during the testing period. This is expected and confirms that a reaction is developing. Your dermatologist documents and photographs the readings systematically.

At the results consultation, your dermatologist explains every positive result, identifies which reactions are clinically relevant to your current dermatitis, distinguishes relevant from incidental sensitizations, reviews the practical implications of each confirmed allergen, and provides your personalized avoidance list and safe product guidance. For most patients, this consultation is the moment at which a chronic, puzzling, repeatedly recurring rash finally makes complete sense.

After Your Evaluation

Following patch testing and the results consultation, most patients with allergic contact dermatitis begin to see progressive improvement as they implement allergen avoidance and continue anti-inflammatory treatment during the active reaction phase. The timeline to full clearance depends on the extent and chronicity of the dermatitis at presentation. Acute reactions typically clear within 2 to 4 weeks with appropriate treatment and complete avoidance. Chronic hand dermatitis that has been present for months may take 6 to 12 weeks of consistent treatment and avoidance to achieve full resolution.

Follow-up appointments track your treatment response and provide an opportunity to troubleshoot incomplete improvement, which frequently indicates ongoing low-level allergen exposure from a product that was not yet identified and eliminated. Your dermatologist adjusts the treatment plan based on your progress and remains accessible for questions between appointments. Once complete remission is achieved through allergen avoidance, most patients remain in remission as long as avoidance is maintained.

Get Clear Answers from Connolly Dermatology

Make Informed Decisions About Your Skin Health

Contact dermatitis is one of the most common inflammatory skin conditions evaluated in dermatology, and one of the most treatable when the causative substance is accurately identified. Allergic contact dermatitis is driven by a T-cell immune response to a specific allergen that can be identified precisely with patch testing. Irritant contact dermatitis results from direct barrier damage by chemical or physical agents that can be reduced through exposure modification and barrier repair. Both forms improve meaningfully with appropriate management and worsen predictably with continued exposure and inadequate treatment.

The key to lasting control is accurate diagnosis. Treating contact dermatitis without identifying the cause produces temporary relief followed by recurrence. Patch testing identifies the specific allergen with certainty, enabling the complete avoidance that produces complete and lasting remission. At Connolly Dermatology, our board-certified dermatologists offer comprehensive contact dermatitis evaluation including detailed history review, clinical examination, patch testing with extended allergen panels when indicated, precise allergen avoidance counseling, and the full range of evidence-based treatments from topical anti-inflammatory therapy through systemic management for severe disease.

If a rash that keeps coming back is affecting your skin, your work, or your quality of life, a professional evaluation provides the answers that over-the-counter treatment cannot. Schedule a visit with a dermatologist to get clear, informed guidance about your skin.